Hims & Hers Health, Inc.

NYSE:HIMS 株式レポート

時価総額:US$5.1b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Hims & Hers Health 将来の成長

Future 基準チェック /46

Hims & Hers Healthは、39.9%と17.8%でそれぞれ年率39.9%で利益と収益が成長すると予測される一方、EPSはgrowで41.9%年率。

主要情報

40.5%

収益成長率

43.0%

EPS成長率

Healthcare 収益成長17.1%
収益成長率18.4%
将来の株主資本利益率n/a
アナリストカバレッジ

Good

最終更新日17 Jun 2024

今後の成長に関する最新情報

Recent updates

Hims & Hers: The Undervalued Gem Poised For Growth

Jun 18

Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable

Jun 10

Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

May 31
Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

May 21

Hims & Hers Health: An Unforced Error

May 06

Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

May 04
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry

Apr 24

Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation

Apr 05

Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock

Mar 21

Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

Mar 12

Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Feb 28
Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Hims & Hers: Turning The Profitability Corner And Returning 28%

Feb 25

Hims & Hers Health: No Clear Moat Besides First Mover Advantage

Jan 23

Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple

Jan 10

Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Jan 07
Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health Q3: The Cheapest Growth Stock Around

Dec 14

Hims & Hers Health: What Would The Author Of 100 Baggers Say?

Nov 30

Hims & Hers: The Most Undervalued Small Cap Stock I See

Nov 08

Hims & Hers: A Promising Company With Resolvable Challenges

Nov 02

Hims & Hers: Specialization Is The Secret To Great Growth

Oct 25

Hims & Hers Health: Can't Get Much Better

Sep 25

The Market Is Wrong On Hims & Hers Health

Sep 18

Hims & Hers: The Current Weakness Creates A Buying Opportunity

Aug 15

Hims & Hers Health: Giving Investors Another Bite At The Apple

Aug 01

Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Jul 21
Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong

Jul 13

Hims & Hers Health: Double-Edged Sword

Jul 02

Hims & Hers: More Transparency Could Help The Stock

Jun 09

Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business

Apr 19
Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business

Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?

Mar 30
Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?

Him & Hers Health Q4 2022 Earnings Preview

Feb 24

Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance

Feb 09

業績と収益の成長予測

NYSE:HIMS - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20261,883109N/A2899
12/31/20251,5477214120013
12/31/20241,229416414513
3/31/2024959-25290N/A
12/31/2023872-244773N/A
9/30/2023793-362745N/A
6/30/2023711-471226N/A
3/31/2023616-59-62N/A
12/31/2022527-66-34-27N/A
9/30/2022444-86-29-23N/A
6/30/2022374-83-51-45N/A
3/31/2022321-73-43-38N/A
12/31/2021272-108-39-34N/A
9/30/2021229-82-36-32N/A
6/30/2021196-72-17-12N/A
3/31/2021171-63-18-13N/A
12/31/2020149-18-7-2N/A
9/30/2020132-25-16-13N/A
6/30/2020112-38-43-41N/A
3/31/202095-58-62-60N/A
12/31/201983-72-77-75N/A
12/31/201827-75-57-57N/A

アナリストによる今後の成長予測

収入対貯蓄率: HIMSは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 2.4% ) よりも高い成長率であると考えられます。

収益対市場: HIMS今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: HIMS今後 3 年以内に収益を上げることが予想されます。

収益対市場: HIMSの収益 ( 17.8% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: HIMSの収益 ( 17.8% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: HIMSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘